Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence in pharmaceutical administration and clinical pharmacy: A comprehensive review of advancements, challenges, and future directions
0
Zitationen
7
Autoren
2026
Jahr
Abstract
The integration of artificial intelligence (AI) into healthcare is reshaping medical disciplines, with hospital pharmacy undergoing a significant paradigm shift from a labor-intensive model to an intelligence-driven one. This comprehensive review examines the transformative role of AI in pharmaceutical administration and clinical pharmacy, synthesizing recent advancements, identifying key challenges, and projecting future directions. In pharmacy management, AI optimizes procurement through intelligent platforms, enhances dispensing accuracy and safety via automated systems and robotic technologies, and revolutionizes pharmacovigilance by shifting from spontaneous reporting to proactive, data-driven signal detection using machine learning (ML) and natural language processing (NLP). In clinical practice, AI-powered clinical decision support systems (AI-CDSS) augment clinician judgment by enabling real-time data analysis and improving therapeutic outcomes, while human-AI collaborative pre-prescription review systems significantly enhance medication safety. Furthermore, AI facilitates personalized medicine through the integration of pharmacogenomics and leverages large language models (LLMs) to improve patient engagement and medication adherence. Crucially, this review argues that AI is not a replacement for pharmacists but a catalyst for redefining their professional roles, elevating them from dispensers to clinical decision-makers and multidisciplinary collaborators. Despite its vast potential, the widespread adoption of AI faces significant hurdles, including poor data quality and interoperability, algorithmic “black-box” issues that undermine trust, ethical and privacy concerns, lagging regulatory frameworks, and a lack of long-term economic validation. Looking ahead, the future of intelligent pharmacy will be shaped by the integration of LLMs with knowledge graphs, the rise of explainable AI (XAI), the implementation of federated learning for secure data sharing, and the establishment of end-to-end digital ecosystems. Ultimately, AI is poised to become an indispensable collaborator in pharmacy, fostering a more efficient, intelligent, and patient-centered ecosystem.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.549 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.443 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.941 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.792 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.
Autoren
Institutionen
- National Health and Family Planning Commission(CN)
- National Institute of Hospital Administration(CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College(CN)
- Sun Yat-sen University(CN)
- Third Affiliated Hospital of Sun Yat-sen University(CN)
- First Affiliated Hospital of Zhengzhou University(CN)
- Ministry of Education(ET)
- Beijing University of Chinese Medicine(CN)